Resources
Mind the Gap
While all men are at risk for prostate cancer, there are disproportionate gaps in treatment, research, clinical trials and mo [...]
Resources
Clinical Validation of a Multimodal Artificial Intelligence Prognostic Model in Localized and Advanced Disease
Artera has developed multimodal AI (MMAI)-enabled predictive and prognostic biomarkers for patients with prostate cancer usin [...]
Resources
ArteraAI Predictive Models
ArteraAI is a leading precision medicine company developing AI tests to personalize cancer therapy. Download the pdf.
Resources
The science behind the ArteraAI Prostate Test
Our test can help identify patients with localized prostate cancer who will benefit from treatment intensification Our AI-ena [...]
Resources
ArteraAI’s Commitment to HIPAA
With ArteraAI’s expansion, we understand that security is a necessity. So we are pleased to announce that ArteraAI is HIPAA c [...]